In an exam room at St. Jude, Johnnie Bass, AuD, PhD, St. Jude Rehabilitation Services, is adjusting a pair of headphones on 11-year-old Eli. Eli, who is in remission from osteosarcoma, a type of bone cancer, smiles as his father jokes with him during his audiology checkup. Eli is getting his hearing checked because some treatments for childhood cancer can place survivors at a greater risk of hearing loss than their peers.
Five years ago, Eli fell. He told his parents, Liliana Patino and Eutimio Castellon, about a persistent pain in his leg. Instead of the fracture they expected to find, an X-ray image revealed a mass on one of his leg bones. Liliana and Eutimio learned the news on a Friday, and by the following Monday, they were referred to and started treatment at St. Jude.
“At first, it was really scary because we didn’t know what was involved in his procedures,” Eutimio said. “But everyone at St. Jude was very compassionate, and they explained everything very simply and clearly.”
“We are so thankful to St. Jude for Eli’s treatment,” Liliana said. “He was taken care of so well because somebody decided to be a part of research here in the past.”
Through a combination treatment refined by St. Jude researchers, Eli is in remission. But during that process, he received chemotherapy with the drug cisplatin. Cisplatin is a type of drug called a platinum chemotherapy, and these drugs are known to damage the ear, which can cause hearing loss. Eli’s care team warned the family that the treatment could diminish his hearing, then screened for and found that loss afterward treatment was complete.
“Sometimes you lose something to gain something bigger,” Eutimio said. “It could have been a lot worse.”
All St. Jude patients receive regular checkups to watch for the side effects most likely to be caused by their specific treatment. That standard follow-up detected Eli’s hearing loss. In Rehabilitation Services, Bass assessed Eli to determine if he was a candidate for hearing aids and then helped adjust the hearing aids to ensure he was benefiting from them. Studies have shown that hearing loss can contribute to issues such as struggling in school or feeling isolated, so intervening right away to make sure Eli doesn’t experience those struggles is an integral part of survivorship care at St. Jude.
Bass researches how hearing loss affects survivors of childhood cancer and how to address it best. While not currently enrolled in one of Bass’s studies, the family is more than willing to help if called to participate in St. Jude research in the future.
“We are still getting a lot of help and support from the hospital even after finishing Eli’s treatment,” Liliana said. “Participating in research is a small way we can give something back to our cancer community.”
Despite the rigors of cancer therapy and developing his hearing loss, Eli still thinks of his time at St. Jude fondly.
“I’m thankful for St. Jude,” he said. “It was fun there.”
More patient stories
-
Running his race: St. Jude survivor goes from patient to researcher
Evan Moore spent the summer of 2025 interning in the laboratory of Victor Torres, PhD, chair of the Department of Host-Microbe Interactions at St. Jude. But his first experience at St. Jude was as a patient with a rare form of Hodgkin's lymphoma.
-
Gauri finds hope in the STEM lab
The STEM lab in the St. Jude School Program changes the life of patient Gauri Patel and inspires a dream. Learn more.
-
Palliative Care: Making Every Day the Best It Can Be
Brayden Gresham faces health challenges with passion and joy, embracing life with a caring family and the St. Jude QoLA team. Learn more.
-
Clinical trial helps Micah and future patients like him
Micah was diagnosed with acute lymphoblastic leukemia and rushed to St. Jude Children’s Research Hospital®. There, his parents chose to enroll him in Total Therapy XVII, a clinical trial. Now he's cancer-free.
-
Fertility Clinic at St. Jude Gives Sandoval Future Options
At 18, Thanaydi Sandoval had her eggs frozen to preserve her fertility before she started cancer treatment. Read about her and the St. Jude Fertility Clinic.
-
Taking Medicine Is Hard, But Help Is Here
Taking medicine as prescribed can be hard, but help is available. Learn how St. Jude helps families overcome medication challenges.
-
It Takes Two: How St. Jude Apps Support Families Every Step of the Way
The Our St. Jude app helps patients and families navigate care, campus, and community with ease—from arrival to everyday needs.
-
Genetic Counseling Helps Mattie Understand Her Condition
Mattie Jenkins has neurofibromatosis type 2 (NF2). Her care team at St. Jude keeps track of her health. Learn more about Mattie, NF2, and genetic counseling.
-
Preschooler’s Energy Shines Despite GVHD Side Effects
After a second transplant for acute myeloid leukemia, St. Jude patient Harry Walker receives extracorporeal photopheresis for graft-versus-host disease.
-
Joy that a Tumor Cannot Touch
Little Olivia Shulov battles seizures caused by a benign tumor. At St. Jude Children’s Research Hospital, she finds hope, support, and joy in her journey.
-
Family, genomics and a first-of-its-kind treatment to cure neuroblastoma
When traditional treatments did not cure her neuroblastoma, Maria Tangonan and her family traveled across the world from the Philippines to St. Jude Children's Research Hospital in Memphis. There, a novel therapy tailored to Maria's specific illness cured her. Learn more.
-
It's Not About Us
St. Jude patient Krystalyn is on the SJ901 trial for low-grade glioma. Learn more about Krystalyn.
-
Melanoma: A skin cancer that does not always need the sun
Alice remains confident, courageous, and strong in her journey to push her melanoma into remission. Read her story.
-
Genetic Testing Provides Answers
After Davis is diagnosed with a rare and aggressive brain tumor, his family finds answers through genetic testing. Learn more.